Solutions4CO2 Inc. ("S4CO2" or the "Company") (TSX VENTURE:SFC) is pleased to
announced today that interest in its current non-brokered private placement (the
"Private Placement") has improved and that it has sought approval from the TSX
Venture Exchange ("TSXV") to increase the Private Placement to a maximum of
2,166,667 units ("Units") at a price of $0.15 per Unit, raising gross proceeds
of up to C$325,000. With $571,500 already closed and together with these funds,
the amount raised will approach the $1 million maximum private placement notice
initially issued on March 18, 2013. 


Each Unit will consist of one common share and one-half of one common share
purchase warrant with each whole warrant entitling the holder to purchase one
common share at a price of C$0.20, for a period of 36 months from the date of
closing. The securities to be issued will be subject to a statutory four
month-plus-one-day hold period from the date of closing.


The Private Placement is being conducted in reliance upon certain prospectus and
registration exemptions. The net proceeds from the Private Placement will be
used to enhance the Company's cash on hand and strengthen its working capital
position. S4CO2 currently has 40,128,011 Common Shares outstanding.


The Private Placement is subject to all applicable regulatory approvals,
including the acceptance of the TSXV.


Douglas Kemp-Welch, CEO of S4CO2 commented: 

"As our joint venture to process North Atlantic shrimp waste into Omega 3
enriched oils is now progressing, it remains prudent for the Company to
strengthen its working capital position as this project and others in our
pipeline such as our Omega 3 rich algae integrated bio-Refinery advances. Our
first commercial run of Omega 3 oil extraction is now scheduled for mid-August
2013."


About Solutions4CO2 Inc.:

Solutions4CO2 Inc. is a Canadian company that develops innovative waste-gas,
water, biomass to high-value nutra co-product solutions using proprietary and
licensed technologies under the trademarks Integrated Biogas Refinery(TM)
("IBR") and Bio-Extraction Process(TM) ("BEP"). The IBR integrates best in class
technologies to convert various organic waste streams into high-value Omega 3
enriched oil co-products for sale into the global nutraceutical market. The BEP
utilizes supercritical CO2 fluid extraction to extract high-value co-products
from shrimp by-products. Solution4CO2's business model allows the Company to
licence or participate in joint-venture projects with partners across the
waste-to-high-value co-product value chain.


Forward-looking Statements

This news release may contain forward-looking statements that are based on
Solutions4CO2 Inc's expectations, estimates and projections regarding its
business and the economic environment in which it operates. These statements are
not guarantees of future performance and involve risks and uncertainties that
are difficult to control or predict. Therefore, actual outcomes and results may
differ materially from those expressed in these forward-looking statements and
readers should not place undue reliance on such statements. Statements speak
only as of the date on which they are made, and the Company undertakes no
obligation to update them publicly to reflect new information or the occurrence
of future events or circumstances, unless otherwise required to do so by law.


Neither the TSX Venture Exchange nor its Regulation Services Provider (as that
term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release.


FOR FURTHER INFORMATION PLEASE CONTACT: 
Solutions4CO2 Inc.
Douglas Kemp-Welch
CEO
416-803-9435


Solutions4CO2 Inc.
Dil Vashi
Manager Corporate Development
416-803-9435 extension 104
www.s4co2.com

Blueocean Nutrasciences, Inc. (TSXV:SFC)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024 Plus de graphiques de la Bourse Blueocean Nutrasciences, Inc.
Blueocean Nutrasciences, Inc. (TSXV:SFC)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024 Plus de graphiques de la Bourse Blueocean Nutrasciences, Inc.